| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1092576388 |
| P356 | DOI | 10.1186/S12936-017-2085-4 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s12936-017-2085-4 |
| P932 | PMC publication ID | 5678585 |
| P698 | PubMed publication ID | 29115999 |
| P50 | author | Alan Fairlamb | Q4706598 |
| Ian H. Gilbert | Q38322743 | ||
| Paul G. Wyatt | Q41782047 | ||
| Beatriz Baragaña | Q55175935 | ||
| Irene Hallyburton | Q114415548 | ||
| Julie A Frearson | Q114415586 | ||
| Torsten Luksch | Q114533529 | ||
| Daniel Spinks | Q117274704 | ||
| P2093 | author name string | Daniel James | |
| David Waterson | |||
| Didier Leroy | |||
| Andrew Woodland | |||
| Raffaella Grimaldi | |||
| P2860 | cites work | The protein kinase complement of the human genome | Q24324497 |
| Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote | Q24792290 | ||
| Targeting Plasmodium PI(4)K to eliminate malaria | Q27974482 | ||
| The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites | Q28480979 | ||
| A novel multiple-stage antimalarial agent that inhibits protein synthesis | Q30044020 | ||
| Drug resistance in eukaryotic microorganisms | Q30248243 | ||
| Protein kinases as targets for anti-parasitic chemotherapy | Q30828981 | ||
| Lessons learnt from assembling screening libraries for drug discovery for neglected diseases | Q33309109 | ||
| Optimisation of the anti-Trypanosoma brucei activity of the opioid agonist U50488 | Q33990598 | ||
| Malaria biology and disease pathogenesis: insights for new treatments | Q34579700 | ||
| Current kinase inhibitors cover a tiny fraction of fragment space. | Q35614315 | ||
| In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen | Q36736936 | ||
| Trisubstituted Pyrimidines as Efficacious and Fast-Acting Antimalarials | Q37101499 | ||
| Discovery of a Quinoline-4-carboxamide Derivative with a Novel Mechanism of Action, Multistage Antimalarial Activity, and Potent in Vivo Efficacy | Q37412029 | ||
| The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? | Q37591585 | ||
| Exploring novel targets for antimalarial drug discovery: plasmodial protein kinases | Q37718296 | ||
| A medicinal chemist's guide to molecular interactions | Q37719514 | ||
| The impact of aromatic ring count on compound developability: further insights by examining carbo- and hetero-aromatic and -aliphatic ring types | Q37815587 | ||
| Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity | Q37894319 | ||
| Plasmodium kinases as targets for new-generation antimalarials | Q38066993 | ||
| Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase. | Q39337756 | ||
| Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic | Q40106428 | ||
| Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. | Q40815932 | ||
| Characteristics of a human diploid cell designated MRC-5. | Q43462188 | ||
| The influence of drug-like concepts on decision-making in medicinal chemistry | Q46922861 | ||
| Global kinomic and phospho-proteomic analyses of the human malaria parasite Plasmodium falciparum | Q47996321 | ||
| A genomic perspective of protein kinases in Plasmodium falciparum | Q56558814 | ||
| Plasmodium falciparum: Assessment of in vitro growth by [3H]hypoxanthine incorporation | Q70238538 | ||
| P433 | issue | 1 | |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| P304 | page(s) | 446 | |
| P577 | publication date | 2017-11-07 | |
| P1433 | published in | Malaria Journal | Q15749954 |
| P1476 | title | Screening a protein kinase inhibitor library against Plasmodium falciparum | |
| P478 | volume | 16 |
| Q64064607 | High-throughput screening of the Plasmodium falciparum cGMP-dependent protein kinase identified a thiazole scaffold which kills erythrocytic and sexual stage parasites |
| Q90914855 | Unpacking the Pathogen Box-An Open Source Tool for Fighting Neglected Tropical Disease |
| Q91871690 | Who Needs a Contractile Actomyosin Ring? The Plethora of Alternative Ways to Divide a Protozoan Parasite |
Search more.